BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 38339274)

  • 21. Androgen receptor splicing variant 7 (ARv7) promotes DNA damage response in prostate cancer cells.
    Luo H; Liu Y; Li Y; Zhang C; Yu B; Shao C
    FASEB J; 2022 Sep; 36(9):e22495. PubMed ID: 35947121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYCLIN K down-regulation induces androgen receptor gene intronic polyadenylation, variant expression and PARP inhibitor vulnerability in castration-resistant prostate cancer.
    Sun R; Wei T; Ding D; Zhang J; Chen S; He HH; Wang L; Huang H
    Proc Natl Acad Sci U S A; 2022 Sep; 119(39):e2205509119. PubMed ID: 36129942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complex impacts of PI3K/AKT inhibitors to androgen receptor gene expression in prostate cancer cells.
    Liu L; Dong X
    PLoS One; 2014; 9(10):e108780. PubMed ID: 25360799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen receptor mutations for precision medicine in prostate cancer.
    Shiota M; Akamatsu S; Tsukahara S; Nagakawa S; Matsumoto T; Eto M
    Endocr Relat Cancer; 2022 Oct; 29(10):R143-R155. PubMed ID: 35900853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Origin, Expression Regulation, and Biological Function of Androgen Receptor Splicing Variant 7 in Prostate Cancer.
    Chen Y; Lan T
    Urol Int; 2021; 105(5-6):337-353. PubMed ID: 32957106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.
    Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK
    Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PARP Inhibitors in Prostate Cancer—The Preclinical Rationale and Current Clinical Development.
    Virtanen V; Paunu K; Ahlskog JK; Varnai R; Sipeky C; Sundvall M
    Genes (Basel); 2019 Jul; 10(8):. PubMed ID: 31357527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancer.
    Agarwal N; Zhang T; Efstathiou E; Sayegh N; Engelsberg A; Saad F; Fizazi K
    Eur J Cancer; 2023 Oct; 192():113249. PubMed ID: 37672815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9
    Wang R; Sun Y; Li L; Niu Y; Lin W; Lin C; Antonarakis ES; Luo J; Yeh S; Chang C
    Eur Urol; 2017 Nov; 72(5):835-844. PubMed ID: 28528814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen receptor: what we know and what we expect in castration-resistant prostate cancer.
    Cai Z; Chen W; Zhang J; Li H
    Int Urol Nephrol; 2018 Oct; 50(10):1753-1764. PubMed ID: 30128923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer.
    Mohler ML; Sikdar A; Ponnusamy S; Hwang DJ; He Y; Miller DD; Narayanan R
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic Approaches to Targeting Androgen Receptor Splice Variants.
    Daniels VA; Luo J; Paller CJ; Kanayama M
    Cells; 2024 Jan; 13(1):. PubMed ID: 38201308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IU1 and enzalutamide combination yields synergistic effects on castration-resistant prostate cancer.
    Zhang Y; Liao Y; Luo M; Ye Y; Xu Z; Hou W; Liu R; Zhai Q; Lv S; Wei Q
    Prostate; 2023 Nov; 83(15):1446-1457. PubMed ID: 37545197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The molecular underpinnings of prostate cancer: impacts on management and pathology practice.
    Rodrigues DN; Boysen G; Sumanasuriya S; Seed G; Marzo AM; de Bono J
    J Pathol; 2017 Jan; 241(2):173-182. PubMed ID: 27753448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ncRNA-mediated overexpression of ubiquitin-specific proteinase 13 contributes to the progression of prostate cancer via modulating AR signaling, DNA damage repair and immune infiltration.
    Cui X; Yu H; Yao J; Li J; Li Z; Jiang Z
    BMC Cancer; 2022 Dec; 22(1):1350. PubMed ID: 36564767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration-resistant prostate cancer.
    Pilling A; Kim SH; Hwang C
    Prostate; 2022 Feb; 82(2):182-192. PubMed ID: 34672379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen-repressed lncRNA LINC01126 drives castration-resistant prostate cancer by regulating the switch between O-GlcNAcylation and phosphorylation of androgen receptor.
    Cai Y; Chen M; Gong Y; Tang G; Shu Z; Chen J; Zhou H; He Y; Long Z; Gan Y
    Clin Transl Med; 2024 Jan; 14(1):e1531. PubMed ID: 38214432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signaling.
    Köhler A; Demir U; Kickstein E; Krauss S; Aigner J; Aranda-Orgillés B; Karagiannidis AI; Achmüller C; Bu H; Wunderlich A; Schweiger MR; Schaefer G; Schweiger S; Klocker H; Schneider R
    Mol Cancer; 2014 Jun; 13():146. PubMed ID: 24913494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of men with metastatic castration-resistant prostate cancer following potent androgen receptor inhibition: a review of novel investigational therapies.
    Labriola MK; Atiq S; Hirshman N; Bitting RL
    Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):301-309. PubMed ID: 33168966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer.
    Perner S; Cronauer MV; Schrader AJ; Klocker H; Culig Z; Baniahmad A
    Oncotarget; 2015 Nov; 6(34):35542-55. PubMed ID: 26325261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.